• Mon news: Autolus enters CAR-T race with FDA approval. FDA clears clinical hold on Novavax. AbbVie schizophrenia trial failure. Cigna not pursuing Humana. GSK leaving BIO. See more on our front page

BELVIQ earned ¥3,714 million (down 16.0% year on year).

















There will be rolling blackouts in the corporate offices to try and cut down on revenue loss. People will work in the dark for half of their days until further notice.